메뉴 건너뛰기




Volumn 43, Issue 12, 2009, Pages 1964-1971

Propylene glycol accumulation in critically ill patients receiving continuous intravenous lorazepam infusions

Author keywords

Adverse effects; Critical care; Lorazepam; Propylene glycol; Sedation; Toxicity

Indexed keywords

ALCOHOL; LORAZEPAM; MIDAZOLAM; PLACEBO; PROPYLENE GLYCOL;

EID: 72249085530     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M313     Document Type: Article
Times cited : (41)

References (10)
  • 2
    • 0004636259 scopus 로고    scopus 로고
    • (accessed 2009 Apr 2)
    • World Health Organization. The International Programme on Chemical Safety (IPCS). www.who.int/ipcs/publications/training-poisons/basic-analytical-tox/en/ index11.html (accessed 2009 Apr 2).
    • The International Programme on Chemical Safety (IPCS)
  • 3
    • 3943098025 scopus 로고    scopus 로고
    • Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults
    • DOI 10.1097/01.CCM.0000134831.40466.39
    • Arroliga AC, Shehab N, McCarthy K, Gonzales JP. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults. Crit Care Med 2004;32:1709-1714 (Pubitemid 39050522)
    • (2004) Critical Care Medicine , vol.32 , Issue.8 , pp. 1709-1714
    • Arroliga, A.C.1    Shehab, N.2    McCarthy, K.3    Gonzales, J.P.4
  • 4
    • 48249134733 scopus 로고    scopus 로고
    • Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity
    • Yahwak JA, Riker RR, Fraser GL, Subak-Sharpe S. Determination of a lorazepam dose threshold for using the osmol gap to monitor for propylene glycol toxicity. Pharmacotherapy 2008;28:984-991
    • (2008) Pharmacotherapy , vol.28 , pp. 984-991
    • Yahwak, J.A.1    Riker, R.R.2    Fraser, G.L.3    Subak-Sharpe, S.4
  • 5
    • 0141456730 scopus 로고    scopus 로고
    • Propylene glycol-associated renal toxicity from lorazepam infusion
    • Yaucher NE, Fish JT, Smith HW, Wells JA. Propylene glycol-associated renal toxicity from lorazepam infusion. Pharmacotherapy 2003;23:1094-1099
    • (2003) Pharmacotherapy , vol.23 , pp. 1094-1099
    • Yaucher, N.E.1    Fish, J.T.2    Smith, H.W.3    Wells, J.A.4
  • 6
    • 30544455514 scopus 로고    scopus 로고
    • Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation
    • DOI 10.1592/phco.2006.26.1.23
    • Barnes BJ, Gerst C, Smith JR, Terrell AR, Mullins ME. Osmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation. Pharmacotherapy 2006;26:23-33. (Pubitemid 43082924)
    • (2006) Pharmacotherapy , vol.26 , Issue.1 , pp. 23-33
    • Barnes, B.J.1    Gerst, C.2    Smith, J.R.3    Terrell, A.R.4    Mullins, M.E.5
  • 8
    • 24944459735 scopus 로고    scopus 로고
    • Propylene glycol toxicity: A severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study
    • DOI 10.1378/chest.128.3.1674
    • Wilson KC, Reardon C, Theodore AC, Farber HW. Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest 2005;128:1674-1681 (Pubitemid 41324463)
    • (2005) Chest , vol.128 , Issue.3 , pp. 1674-1681
    • Wilson, K.C.1    Reardon, C.2    Theodore, A.C.3    Farber, H.W.4
  • 9
    • 0028354462 scopus 로고
    • Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients
    • Riker RR, Fraser GL, Cox PM. Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med 1994;22:433-440
    • (1994) Crit Care Med , vol.22 , pp. 433-440
    • Riker, R.R.1    Fraser, G.L.2    Cox, P.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.